Dr. Cyrille Richard, 53, is a distinguished Directeur de recherche at the Unité de Technologies Chimiques et Biologiques pour la Santé (UTCBS), Faculté de Pharmacie, Paris. He earned his Doctorate in Organic Chemistry from Université Paris XI-Orsay in 2000, following a DEA in 1996, both with highest honors, and obtained his Habilitation à diriger des recherches from Université Paris Descartes in 2015. Dr. Richard’s professional trajectory includes postdoctoral research at Pittsburgh, USA, and Aventis Pharma, as well as CNRS appointments from Chargé de recherches 2ᵉ classe to Directeur de recherche 2ᵉ classe since 2018. His work focuses on organic chemistry, nanoparticle synthesis, surface functionalization, and the development of chemical probes for in vivo imaging, therapy, and in vitro diagnostics, with expertise in optical imaging, nanoparticle biodistribution, and ELISA-based diagnostics. Over 2018–2025, he led major projects, including national ANR grants (PLEaSe, Stric-on) and international collaborations (FET Open, CSC), supervising 4 PhD students, 3 postdocs, and 15 master’s students, attracting international talent from China, India, Brazil, Ecuador, Egypt, and Canada. He has filed a patent (WO 2024/061937 A1) and published 35 high-impact articles (7 with IF >10), 2 book chapters, amassing 8,840 citations with an H-index of 42. His research is highly collaborative, with national, industrial, and international partnerships, and he actively contributes to scientific governance, serving on 11 doctoral juries, 6 master juries, and numerous project and manuscript review committees for journals such as Nature Nanotechnology, ACS Nano, and Angewandte Chemie. He has been invited to present at eight international conferences and participates in strategic initiatives, including the CNRS laboratory council and the Institut de Chimie Biologique steering committee. Dr. Richard’s contributions have been recognized through awards such as a “Best Paper Prize” and an individual CNRS prime (2024–2027), reflecting his leadership in chemical biology, nanomedicine, and translational research that bridges innovation, diagnostics, and therapeutic applications.
Profiles: Google Scholar | Scopus | ORCID | ResearchGate | LinkedIn
Featured Publications
-
Maldiney, T., Bessière, A., Seguin, J., Teston, E., Sharma, S. K., Viana, B., Bos, A. J. J., … (2014). The in vivo activation of persistent nanophosphors for optical imaging of vascularization, tumours and grafted cells. Nature Materials, 13(4), 418–426. Cited by 1104
-
Richard, C., Balavoine, F., Schultz, P., Ebbesen, T. W., & Mioskowski, C. (2003). Supramolecular self-assembly of lipid derivatives on carbon nanotubes. Science, 300(5620), 775–778. Cited by 1000
-
Balavoine, F., Schultz, P., Richard, C., Mallouh, V., Ebbesen, T. W., … (1999). Helical crystallization of proteins on carbon nanotubes: A first step towards the development of new biosensors. Angewandte Chemie International Edition, 38(13-14), 1912–1915. Cited by 697
-
Maldiney, T., Lecointre, A., Viana, B., Bessière, A., Bessodes, M., Gourier, D., … (2011). Controlling electron trap depth to enhance optical properties of persistent luminescence nanoparticles for in vivo imaging. Journal of the American Chemical Society, 133(30), 11810–11815. Cited by 433
-
Bessière, A., Sharma, S. K., Basavaraju, N., Priolkar, K. R., Binet, L., Viana, B., … (2014). Storage of visible light for long-lasting phosphorescence in chromium-doped zinc gallate. Chemistry of Materials, 26(3), 1365–1373. Cited by 412
